Guidant issues second consecutive performance warning
This article was originally published in Clinica
Guidant has warned that its fourth-quarter revenues will be below analysts' estimates and that its earnings per share will be down by between two and three cents as a result. Analysts were expecting earnings of 43 cents a share, compared with 36 cents a year ago. The announcement follows a similar warning by the company in October for its third-quarter sales (see Clinica No 929, p 13).